The Department proposes to establish fees for registration with the Alaska prescription drug monitoring program's controlled substance prescription database (PDMP) by a pharmacist who dispenses or a practitioner who prescribes, administers, or directly dispenses a schedule II, III, of IV controlled substance under federal law as required under AS 17.30.200. 

The AKAPA is actively working on a response to the proposed changes. Questions, comments and concerns can be directed to info@akapa.org. Updates will be sent to members as they become available including the AKAPAs formal response and information on how individuals can respond as well. 

Click here to review full proposed regulation changes

Click here PDMP Regulation Fees FAQ